A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases

J Clin Immunol. 2020 Feb;40(2):267-276. doi: 10.1007/s10875-019-00731-3. Epub 2019 Dec 19.

Abstract

We report three new cases of a germline heterozygous gain-of-function missense (p.(Met1141Lys)) mutation in the C2 domain of phospholipase C gamma 2 (PLCG2) associated with symptoms consistent with previously described auto-inflammation and phospholipase Cγ2 (PLCγ2)-associated antibody deficiency and immune dysregulation (APLAID) syndrome and pediatric common variable immunodeficiency (CVID). Functional evaluation showed platelet hyper-reactivity, increased B cell receptor-triggered calcium influx and ERK phosphorylation. Expression of the altered p.(Met1141Lys) variant in a PLCγ2-knockout DT40 cell line showed clearly enhanced BCR-triggered influx of external calcium when compared to control-transfected cells. Our results further expand the molecular basis of pediatric CVID and phenotypic spectrum of PLCγ2-related defects.

Keywords: Germline PLCγ2 mutations; PLCγ2 C2 domain.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmunity / genetics
  • B-Lymphocytes / immunology*
  • Calcium Signaling
  • Cell Line
  • Child
  • Child, Preschool
  • Common Variable Immunodeficiency / diagnosis*
  • Female
  • Germ-Line Mutation / genetics*
  • Humans
  • Immunologic Deficiency Syndromes / diagnosis*
  • Infant
  • Male
  • Mutation, Missense / genetics*
  • Phenotype
  • Phospholipase C gamma / genetics*
  • Protein Domains / genetics

Substances

  • Phospholipase C gamma